Watch YCBD. Know when insiders buy.
One email the day a filing lands. Free.
YCBD
cbdMD, Inc.
0.46
+0.00 +1.11%
USD · close Oct 2
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
36
FLAG · shorts 36
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $5.1MP/E 1.9DIV YIELD —FCF YIELD -47.15%REV TTM $20.9M +10.0%NET INCOME −$2.9MNET CASH $2.1M52W 0.44 – 2.27SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 · Jun 30 | $5.6M | +20.6% | 54.7% | −$1.1M | −$1.1M | — | -0.11 | −$442K | $18K | −$460K | Aug 13 |
| Q2 2026 · Mar 31 | $5.6M | +18.8% | 57.7% | −$801K | −$798K | — | -0.08 | −$723K | $6K | −$728K | May 14 |
| Q1 2026 · Dec 31 | $5M | −1.9% | 59.8% | −$286K | −$283K | −1975.7% | -0.04 | −$812K | $165K | −$977K | Feb 17 |
| Q4 2025 · Sep 30derived | $4.7M | +3.6% | 58.8% | −$686K | −$680K | — | 0.47 | −$241K | $3K | −$244K | Dec 19 |
| Q3 2025 · Jun 30 | $4.6M | −11.0% | 61.5% | −$905K | −$895K | −294.7% | -0.21 | −$704K | $1K | −$706K | Aug 13 |
| Q2 2025 · Mar 31 | $4.7M | +8.5% | 62.3% | −$486K | −$481K | — | -1.90 | −$189K | $16K | −$205K | May 14 |
| Q1 2025 · Dec 31 | $5.1M | −4.9% | 66.5% | −$86K | $15K | — | -1.73 | −$318K | $164K | −$482K | Feb 17 |
| Q4 2024 · Sep 30 | $4.6M | −20.2% | 53.9% | −$317K | −$153K | — | -12.45 | $167K | $10K | $157K | Dec 19 |
| Q3 2024 · Jun 30 | $5.2M | — | 65.8% | −$382K | $460K | — | -0.15 | $290K | $0 | $290K | Aug 14 |
| Q2 2024 · Mar 31 | $4.4M | — | 59.0% | −$1.6M | −$3M | — | -1.35 | −$704K | −$5K | −$699K | Aug 14 |
| Q1 2024 · Dec 31 | $5.4M | — | 66.2% | −$1.1M | −$997K | — | -0.67 | −$106K | $185K | −$291K | Aug 14 |
| Q4 2023 · Sep 30 | $5.7M | — | 62.1% | −$15.2M | −$15.9M | — | -9.06 | −$264K | $120K | −$384K | Dec 18 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Sep 30 | $19.2M | 62.4% | −$2.2M | −$2M | -10.6% | -1.09 | −$1.5M | $184K | −$1.6M | — | — |
| FY2024 · to Sep 30 | $19.5M | 61.6% | −$3.3M | −$3.7M | -19.0% | -14.29 | −$353K | $190K | −$543K | — | — |
| FY2023 · to Sep 30 | $24.2M | 62.0% | −$22.5M | −$22.9M | -95.0% | -13.32 | −$4.3M | $298K | −$4.6M | — | — |
| FY2022 · to Sep 30 | $35.4M | 63.1% | −$78.3M | −$70.1M | -198.0% | -55.80 | −$15M | $689K | −$15.7M | — | — |
| FY2021 · to Sep 30 | $44.5M | 67.4% | −$19.6M | −$23.4M | -52.6% | -0.47 | −$14.1M | $342K | −$14.4M | — | $2.6M |
| FY2020 · to Sep 30 | $41.9M | 63.0% | −$17.6M | $12.6M | 30.1% | 0.28 | −$10.7M | $1.3M | −$12M | — | $367K |
Every number comes from cbdMD, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.